Ayrton Saunders

Ayrton Saunders is a UK-based specialty pharmaceutical and medical device company focused on the development, licensing, and commercialization of aerosol-based treatments and other niche products. A subsidiary of OBG Pharmaceuticals (under Noveayr Therapeutics), the company specializes in respiratory, cardiovascular, and dermatological therapies delivered via oral inhalation, nasal, topical, and oro-mucosal routes. Its notable products include the Voke nicotine inhaler system, a clinically approved, heat-free nicotine replacement therapy (NRT) that delivers nicotine directly to the lungs, and Glytrin, a sublingual glyceryl trinitrate spray for acute angina pectoris. Ayrton Saunders operates primarily through a partnership and licensing model, collaborating with global pharmaceutical companies to commercialize its aerosol and topical drug delivery technologies.